Rep. Ro Khanna bought Colgate-Palmolive Company (CL)
Rep. Ro Khanna (D-CA-17) · $1K–$15K · traded Oct 2, 2023
- Transaction
- Bought
- Amount
- $1K–$15K
- Owner
- Not stated
- Traded
- Oct 2, 2023
- Disclosed
- Nov 8, 2023
- Days to disclose
- 37
- Asset type
- Stock
- As filed
- Colgate-Palmolive Co
- Industry
- Household & Personal Products · Consumer Defensive
Other trades in this filing
All of Khanna's trades →- Nov 8, 2023$15K–$50K
$15K–$50K · Traded Oct 31, 2023 · disclosed Nov 8, 2023 · Spouse
- Nov 8, 2023$1K–$15K
$1K–$15K · Traded Oct 31, 2023 · disclosed Nov 8, 2023 · Spouse
- Nov 8, 2023$1K–$15K
Bought Thermo Fisher Scientific TMO
$1K–$15K · Traded Oct 31, 2023 · disclosed Nov 8, 2023 · Spouse
- Nov 8, 2023$15K–$50K
Bought Prudential Financial PRU
$15K–$50K · Traded Oct 31, 2023 · disclosed Nov 8, 2023 · Spouse
- Nov 8, 2023$1K–$15K
Sold Old Dominion Freight Line ODFL
$1K–$15K · Traded Oct 31, 2023 · disclosed Nov 8, 2023 · Spouse
- Nov 8, 2023$1K–$15K
Bought The Interpublic Group of Companies IPG
$1K–$15K · Traded Oct 31, 2023 · disclosed Nov 8, 2023 · Spouse
- Nov 8, 2023$1K–$15K
$1K–$15K · Traded Oct 31, 2023 · disclosed Nov 8, 2023 · Spouse
- Nov 8, 2023$1K–$15K
$1K–$15K · Traded Oct 31, 2023 · disclosed Nov 8, 2023 · Spouse
- Nov 8, 2023$1K–$15K
$1K–$15K · Traded Oct 31, 2023 · disclosed Nov 8, 2023 · Spouse
- Nov 8, 2023$1K–$15K
$1K–$15K · Traded Oct 31, 2023 · disclosed Nov 8, 2023 · Spouse
- Nov 8, 2023$1K–$15K
$1K–$15K · Traded Oct 31, 2023 · disclosed Nov 8, 2023 · Spouse
- Nov 8, 2023$1K–$15K
$1K–$15K · Traded Oct 31, 2023 · disclosed Nov 8, 2023 · Spouse
- Nov 8, 2023$1K–$15K
$1K–$15K · Traded Oct 31, 2023 · disclosed Nov 8, 2023 · Spouse
- Nov 8, 2023$1K–$15K
$1K–$15K · Traded Oct 31, 2023 · disclosed Nov 8, 2023 · Spouse
- Nov 8, 2023$1K–$15K
$1K–$15K · Traded Oct 31, 2023 · disclosed Nov 8, 2023 · Spouse
- Nov 8, 2023$1K–$15K
$1K–$15K · Traded Oct 31, 2023 · disclosed Nov 8, 2023 · Spouse
- Nov 8, 2023$1K–$15K
$1K–$15K · Traded Oct 31, 2023 · disclosed Nov 8, 2023 · Spouse
- Nov 8, 2023$1K–$15K
Bought Genuine Parts Company GPC
$1K–$15K · Traded Oct 31, 2023 · disclosed Nov 8, 2023 · Spouse
- Nov 8, 2023$1K–$15K
Bought Fidelity National Information Services FIS
$1K–$15K · Traded Oct 31, 2023 · disclosed Nov 8, 2023 · Spouse
- Nov 8, 2023$50K–$100K
$50K–$100K · Traded Oct 31, 2023 · disclosed Nov 8, 2023 · Spouse
Recent Congress trades in CL
- Oct 7, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
Sold Colgate-Palmolive Company CL
$1K–$15K · Traded Sep 25, 2026 · disclosed Oct 7, 2026 · Spouse
- Oct 7, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
Sold Colgate-Palmolive Company CL
$1K–$15K · Traded Sep 11, 2026 · disclosed Oct 7, 2026 · Dependent
- Sep 25, 2026$1K–$15K
Rep. Kevin Hern (R-OK-1)
Sold (partial) Colgate-Palmolive Company CL
$1K–$15K · Traded Sep 2, 2026 · disclosed Sep 25, 2026 · Joint
- Sep 25, 2026$1K–$15K
Rep. Kevin Hern (R-OK-1)
Sold Colgate-Palmolive Company CL
$1K–$15K · Traded Aug 31, 2026 · disclosed Sep 25, 2026
- Sep 25, 2026$1K–$15K
Rep. Kevin Hern (R-OK-1)
Sold (partial) Colgate-Palmolive Company CL
$1K–$15K · Traded Aug 27, 2026 · disclosed Sep 25, 2026
- Sep 1, 2026$1K–$15K
Rep. Kevin Hern (R-OK-1)
Sold Colgate-Palmolive Company CL
$1K–$15K · Traded Aug 19, 2026 · disclosed Sep 1, 2026 · Joint
- Aug 5, 2026$1K–$15K
Rep. Julie Johnson (D-TX-32)
Sold Colgate-Palmolive Company CL
$1K–$15K · Traded Sep 23, 2025 · disclosed Aug 5, 2026 · Joint · filed 316 days later
- Aug 5, 2026$1K–$15K
Rep. Julie Johnson (D-TX-32)
Bought Colgate-Palmolive Company CL
$1K–$15K · Traded Sep 23, 2025 · disclosed Aug 5, 2026 · Joint · filed 316 days later
Company context for CL
Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.
CL: 10-Q financial filing
Filed 10-Q for an event or period dated 2026-09-30. Read the company report for its disclosures.
CL: Financial results
Filed 8-K for an event or period dated 2026-10-30. Financial results.
CL: third_quarter 2026 lobbying report
FDA and HHS engagement regarding oral health, medical research, issues related to the contents and manufacturing of oral care products FDA and HHS engagement regarding oral health, medical research, issues related to the contents and manufacturing of oral care products FDA and HHS engagement regarding oral health, medical research, issues related to the contents and manufacturing of oral care products
Public: Oct 17, 2026, 8:49 PM EDTOriginal source ↗
From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.